DermaLayr is a functional platform that delivers exclusive formulations and hero ingredients deep into the skin for targeted benefit or treatment. A highly convenient all-in-one solution that can deliver multiple activities into the skin in one step.
When testing against serums, DermaLayr delivers actives up to 10 times deeper into the skin layers.
Against gels, DermaLayr is 150% more effective in delivering actives to the skin.
DermaLayr actively combats fine lines and wrinkles, dramatically reducing their appearance.
Results showed an average decrease of 11.6% of observed wrinkles after a single application of DermaLayr.*
DermaLayr visibly smooths the skin’s appearance and helps it regain its firmness and elasticity.
Results showed an average increase of 26.9% observed lifting effect after a single application of DermaLayr.*
With targeted delivery, DermaLayr is scientifically proven to deliver actives deep into the dermal layers.
Results showed that our base formulation, DermaLayr Marine+ containing Salicylic acid enabled a 91.3% penetration of bioactive.
After 15 minutes, delivery starts within the epidermis layer, breaking the stratum corneum skin barrier and providing sustainable release over the first 4 hours.
From 4 to 8 hours, penetration into the dermal layer is shown to rapidly increase up to a concentration of 2.6ug/ml, delivering the actives to where they really work.
No animal testing
Rapid delivery into dermal layers*
100% naturally derived
Clinically proven wrinkle reduction*
No fillers or preservatives
Non-invasive
Through dedication and disruptive innovation, DermaLayr’s Proprietary technology with IP trademarks, filed in three classes across seven countries has changed the game with exceptional performance, measurably greater benefit, and superior experience.
Patent No. NZ711906
Granted
Patent No. US9775917
Granted
Patent No. CN20148026904
Pending
Patent No. KR10-2022-7015361
Pending
Patent No. 201910992361.1
Pending
Patent No. 42021039987.9
Pending
Patent No. CN201910992362
Pending
Patent No. 42021039986.1
Pending
Patent No. CN201910992250
Pending
Patent No. 42021039985.3
Pending
Patent No. JP2022-519009
Pending
Patent No. EP20875420.0
Pending
Patent No. AU2020364515
Pending
*Test conducted on DermaLayr Marine+ Pure Collagen by the Korea Institute of Dermatological Sciences, as used in the Korean product ActivLayr – Cosmoreplus
**Tested by MS Clinical Research, an SGS accredited lab that is ISO-certified